Durvalumab: an investigational anti-PD-L1 antibody for the treatment of biliary tract cancer
Author:
Affiliation:
1. Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy
2. Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13543784.2021.1897102
Reference83 articles.
1. Cholangiocarcinoma 2020: the next horizon in mechanisms and management
2. Molecular targeted therapies: Ready for “prime time” in biliary tract cancer
3. Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future Perspectives
4. Patterns of Initial Disease Recurrence after Resection of Biliary Tract Cancer
5. Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer
Cited by 90 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The role of immune checkpoint inhibitors in the first-line treatment for patients with advanced biliary tract cancer: a systematic review and meta-analysis of randomized trials;Frontiers in Oncology;2024-07-18
2. Unilateral drainage and chemotherapy prolong the patency of a plastic stent placed above the sphincter of Oddi in patients with malignant hilar biliary obstruction;DEN Open;2024-07-15
3. Evaluating the Therapeutic Potential of Durvalumab in Adults with Locally Advanced or Metastatic Biliary Tract Cancer: Evidence to Date;OncoTargets and Therapy;2024-05
4. Sex disparity in clinical characteristics and long-term prognosis after liver resection for patients with intrahepatic cholangiocarcinoma: A propensity score matching analysis;Heliyon;2024-05
5. An advanced culture methodology suitable for the self-assemble and tissue-fragment derived intrahepatic cholangiocarcinoma organoids;Cell Organoid;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3